Take Your Medicine

Mukherjee, Siddhartha
July 2000
New Republic;07/24/2000, Vol. 223 Issue 4, p16
Offers a rationale for why marketing cheaper anti-HIV drugs from western drug companies in Africa could be more harmful than altruistic. Likelihood that patients would be monitored poorly and could relapse, making the virus stronger; Suggestion that pharmaceuticals should build up adequate health care facilities instead; Idea by Glaxo Wellcome PLC to sell HIV drugs in selected areas to prevent drug misuse and subsequent virus resistance.


Related Articles

  • The Dose-Response Relationship of Peginterferon Alfa-2a and Ribavirin in the Treatment of Patients Coinfected with HIV-HCV. Opravil, Milos; Rodriguez-Torres, Maribel; Rockstroh, Jürgen; Snoeck, Eric; Chung, Raymond T.; Tietz, Andreas; Torriani, Francesca J. // HIV Clinical Trials;Jan/Feb2012, Vol. 13 Issue 1, p33 

    Purpose: The relationship between peginterferon/ribavirin exposure and the probability of achieving a sustained virologic response (SVR) in HIV-HCV coinfected patients is not well described. We conducted a retrospective analysis of HIV-HCV coinfected patients randomized to 48 weeks of treatment...

  • Physiological and performance effects of pyridostigmine bromide in healthy volunteers: a dose-response study. Cook, Mary R.; Graham, Charles; Sastre, Antonio; Gerkovich, Mary M. // Psychopharmacology;2002, Vol. 162 Issue 2, p186 

    Presents a dose-response study to determine the physiological and behavioral effects of the drug pyridostigmine bromide. Methods; Results; Conclusion that pyridostigmine bromide does not appear to have detrimental physiological or performance consequences at the doses studied.

  • Antibody to gp41 MPER Alters Functional Properties of HIV-1 Env without Complete Neutralization. Kim, Arthur S.; Leaman, Daniel P.; Zwick, Michael B. // PLoS Pathogens;Jul2014, Vol. 10 Issue 7, p1 

    Human antibody 10E8 targets the conserved membrane proximal external region (MPER) of envelope glycoprotein (Env) subunit gp41 and neutralizes HIV-1 with exceptional potency. Remarkably, HIV-1 containing mutations that reportedly knockout 10E8 binding to linear MPER peptides are partially...

  • Optimizing Adherence to Preexposure and Postexposure Prophylaxis: The Need for an Integrated Biobehavioral Approach. Blashill, Aaron J.; Ehlinger, Peter P.; Mayer, Kenneth H.; Safren, Steven A. // Clinical Infectious Diseases;2015 Supplement, Vol. 60, pS187 

    Preexposure prophylaxis (PrEP) and postexposure prophylaxis (PEP) has been shown to be effective in preventing transmission of human immunodeficiency virus (HIV). A dose-response relationship between adherence and HIV transmission is illustrated in the current PrEP literature, and adherence...

  • Responses to Drug Therapy in Ulcerative Colitis. Korelitz, Burton I.; Sommers, Sheldon C. // American Journal of Gastroenterology;Nov1975, Vol. 64 Issue 5, p365 

    To evaluate responses to medical therapy in ulcerative colitis, rectal biopsies of patients with active untreated disease, individuals with positive and negative sigmoidoscopic findings treated with salieylazosulfapyridine, prednisone and 6-mercaptopurine, alone and in combinations and...

  • HORMESIS: Principles and Applications for Pharmacology and Toxicology. Calabrese, Edward J. // American Journal of Pharmacology & Toxicology;2008, Vol. 3 Issue 1, p56 

    The present assessment places hormetic dose responses within an historical context, documenting its origin, rejection by the biomedical community during the early decades of the 20th due to its close association with homeopathy and its revitalization during the later decades of the past century...

  • Low-dose fixed combo hormonal therapy outranks higher dose.  // PharmacoEconomics & Outcomes News;2/11/2006, Issue 496, p5 

    The article discusses research being done on the cost per additional quality-adjusted life-year (QALY) gained associated with various estrogen/medroxyprogesterone dosage. It references a study by J. A. Swift, P. Conway and D. W. Purdie in the December 2005 issue of "Current Medical Research and...

  • Simulated Drug Administration: An Emerging Tool for Teaching Clinical Pharmacology During Anesthesiology Training. Struys, M. M. R. F.; De Smet, T.; Mortier, E. P. // Clinical Pharmacology & Therapeutics;Jul2008, Vol. 84 Issue 1, p170 

    A thorough understanding of the dose–response relationship is required for optimizing the efficacy of anesthetics while minimizing adverse drug effects.1 Nowadays, except for the inhaled anesthetics (for which end-tidal concentrations can be measured online), most of the drugs used in...

  • potency of a drug.  // Royal Society of Medicine: Medicines;2002, p448 

    The article presents a definition for the term potency of a drug, which refers how strong the drug is, either in terms of the dose required to achieve a given effect, or the maximum effect that is achievable.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics